DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

Published:2016-01 Issue:1 Volume:22 Page:61-70
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ahn Jae-Sook,Kim Hyeoung-Joon,Kim Yeo-Kyeoung,Lee Seun-Shin,Jung Sung-Hoon,Yang Deok-Hwan,Lee Je-Jung,Kim Nan Young,Choi Seung Hyun,Jung Chul Won,Jang Jun-Ho,Kim Hee Je,Moon Joon Ho,Sohn Sang Kyun,Won Jong-Ho,Kim Sung-Hyun,Kim Dennis Dong Hwan

Funder

National Project for Personalized Genomic Medicine

National Research Foundation of Korea (NRF)

Research Institute of Medical Sciences

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference54 articles.

1. DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome;El Ghannam;Blood Cells Mol Dis,2014

2. Epigenetics in cancer;Esteller;N Engl J Med,2008

3. The epigenetic landscape of acute myeloid leukemia;Conway O'Brien;Adv Hematol,2014